Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
G C Davis, A C Williams, S P Markey, M H Ebert, E D Caine, C M Reichert, I J Kopin
Index: Psychiatry Res. 1 , 249-254, (1979)
Full Text: HTML
Abstract
Abuse of 4-propyloxy-4-phenyl-N-methylpiperidine, a meperidine congener, produced parkinsonism in a 23-year-old man. Unlike other drug-induced motor disturbances, the syndrome persisted for 18 months and responded to drugs that stimulate dopamine receptors. Biogenic amines and metabolites in the cerebrospinal fluid and microscopic evaluation of the brain at necropsy were consistent with damage to aminergic neurons in the substantia nigra.
Related Compounds
Related Articles:
2013-01-01
[PLoS ONE 8(5) , e63527, (2013)]
[J. Chromatogr. A. 408 , 356-9, (1987)]
Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.
2005-06-01
[Glycobiology 15(6) , 585-91, (2005)]
2008-09-01
[Immunology 125(1) , 80-90, (2008)]
Modulation of amyloid precursor protein processing by synthetic ceramide analogues.
2010-08-01
[Biochim. Biophys. Acta 1801(8) , 887-95, (2010)]